Bloomberg News

Astellas to Consider Increasing Dividend, CEO Hatanaka Says

November 02, 2011

Nov. 2 (Bloomberg) -- Astellas Pharma Inc., Japan’s third- largest drugmaker, will consider raising its dividend, which is a higher priority than a share buyback, Chief Executive Officer Yoshihiko Hatanaka said at a briefing in Tokyo today.

To contact the reporter on this story: Kanoko Matsuyama in Tokyo at

To contact the editor responsible for this story: Jason Gale at

China's Killer Profits
blog comments powered by Disqus